Novo Nordisk A/SNVO

Where NVO's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$44.56-0.60 (-1.33%)Previous close
NYSEHealthcare

NVO P/E ratio: current value, 10-year range and year-by-year history

10.9Near historic low

NVO's p/e ratio is lower than 95% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
NVO P/E ratio historyNVO P/E ratio from Sep 2023 to Sep 2026: low 8.6, high 51.46, latest 10.93.5.1717.630.0342.4654.89Sep 23Apr 24Nov 24Jul 25Feb 26Sep 26med 24.09

NVO P/E ratio by year

Yearly range of NVO’s p/e ratio from 2016 to 2026. Over the full period it ranged from 8.6 to 51.5, averaging 26.4.

NVO P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20268.611.717.510.9
202511.718.428.814.1
202427.542.751.527.5
202334.740.846.541.8
202229.735.440.840.7
202123.129.538.435.3
202021.124.627.123.7
201919.121.524.323.6
201817.019.824.218.9
201714.117.922.222.1
201613.716.621.015.6

Get notified when NVO P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is NVO P/E ratio High or Low Right Now?

Novo Nordisk A/S's P/E ratio is currently 10.9, which is near historic low relative to its 10-year historical range. The 10-year median P/E ratio for NVO is approximately 23.6. See all NVO valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.